My guests today are Daniel Goldberg and Tim Schlidt, founders of the Palo Santo fund. The two them an their really impressive team got a big plan for the coming years: investing across the new psychedelic ecosystem and funding a new paradigm in well being.Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world. Daniel Goldberg began seeing mental health as part of a spectrum and not something that needs to be so pathologized.As a founder of Palo Santo and Bridge Investments, Daniel has been actively investing with and supporting inspired entrepreneurs for 20 years. Years ago he saw the transformational potential of psychedelic medicines and has developed a deep network of relationships across the psychedelic research and business communities. His passion for the space is purpose‐driven and science informed. He is thrilled to be a part of Palo Santo’s mission of supporting promising treatments while ensuring widespread access to safe, legal, and effective solutions. Tim Schlidt brings extensive knowledge investing across life sciences and healthcare services, and has held a lifelong passion for understanding and improving treatments for CNS disorders. He believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-founding Palo Santo is to invest in companies and solutions that allow for broad access to those most in need of mental health care. Prior to co-founding Palo Santo, Tim covered the life sciences and health care services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill. We talk about Daniels and Tims personal psychedelic experience they had BEFORE the founding of Palo Santo, the shift and the incredible change they saw coming, when a new generation of scientists engaged in psychedelics, about the psychedelic pharma model and what compound is Daniels and Tims favorite and we chat about what will possibly be happening and what I will see, if I would dare to take 5 MEO DMT: but that will happen on the next episode. https://www.palosanto.vc

THE NEW HEALTH CLUB

Palo Santo Fund - How will psychedelic pharma look like?

Dave Rabin is an MD, PhD, a neuroscientist, board-certified psychiatrist, health tech entrepreneur & inventor who has been studying the impact of chronic stress in humans for nearly 15 years, particularly non-invasive therapies for treatment-resistant illnesses like PTSD. He is the co-founder & chief innovation officer at Apollo Neuroscience and the co-founder & executive director of The Board of Medicine. In addition to his clinical psychiatry practice, Dr. Rabin is currently conducting research on the epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic-assisted psychotherapy and the neurobiology of belief. He is a practitioner of ketamine assisted psychotherapy (KAP) and is trained in MDMA assisted psychotherapy. With Molly Maloof, Dr. Dave Rabin is co-hosting the psychedelic news hour on clubhouse.(https://www.psychedelicnewshour.com/) We Talk about listeners on Club House that call in high and how to give them a little integration therapy on air . We talk about why epigenetic trauma is such specific thing, hardly explored, but now a really big topic in the psychedelic context and we talk benefits of Ketamine therapy done at home and of course we talk about Dr Rabins company Apollo. Apollo Neuroscience was born from research at the University of Pittsburgh. David Rabin and Greg Siegle PhD worked together at the Program in Cognitive Affective Neuroscience to develop and scientifically prove out the Apollo technology and discovered that certain combinations of low frequency inaudible sound waves (vibration that you can feel, but can’t hear) can safely and reliably change how we feel through our sense of touch, and that we can measure those physiological changes in near real time. Think of Apollo as a smart bracelet that you can wear around your wrist or ankle and works to give you stress-reducing buzzes in times of need. It syncs to the brand’s app, so you can control its touch therapy functions from your phone.I used Apollo often during the pandemic last year and I fell asleep much easier with it, so I can highly recommend it. Apollo calms your nervous system down in very gentle, but effective way. And since you are a part of amazing the The New Health Club Community, you get a 10% discount on the order of the Apollo. Just head over to www.apolloneuro.com and put in the promo code “newhealth 10” Apollo Partner One Sheet Dr. David Rabin's website Apollo Apollo Research

“Dr Dave Rabin - Mental Health is a whole body experience”

What if Palestinians and Israelis would do an ayahuasca ceremony together? Would there ne more empathy and mutual understanding after the ceremonies? Scientist Leor Roseman and Peace Activist Antwan Saca really wanted to see what happened then. And so they arranged it, and created a study for The Imperial College in London. They recently launched the study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Leor Roseman is a postdoc at the Centre for Psychedelic Research, Imperial College London, where he received his Ph.D. and MRes, under the supervision of Dr. Robin Carhart-Harris and Prof. David Nutt. His research is focused on the neural and psychological correlates of the psychedelic experience, and the therapeutic application of psilocybin for depression. Currently, Leor is investigating the psychosocial potential of psychedelics. Antwan Saca was born in Jerusalem to a Christian family from the city of Bethlehem. He has spent his adult life working towards the dream of peace and justice in the Holy Land. He spent five years at the Holy Land Trust serving also as director of programs, where he experienced community-healing approaches that strengthened his interest in non-violent compassionate activism. Since then, he’s focused on community dynamics and the many forms of personal/collective experienced and inherited trauma that influence conflict resolution in the Holy Land. He believes that healing the pain of the past is a prerequisite for healthy relations between nations and—ultimately—peace. Antwan serves as an associate at Leaders Quest. https://www.frontiersin.org/articles/10.3389/fphar.2021.607529/full https://www.imperial.ac.uk/people/leor.roseman13 http://www.leadersquest.org

Relational Processes in Ayahuasca Groups of Palestinians and Israelis

Diana Kinnert is a German politician, political consultant, and publisher. In 2015 she became the youngest chief of staff in the history of the Bundestag when she ran the parliamentary office of Peter Hintze. She is a frequent media commentator on public policy in Germany, and is affiliated with a number of think tanks and advisory committees of the Christian Democratic Union of Germany. Kinnert has the right amount of forward thinking and meeting people where they are at. She is also a firm believer that mental health becomes one of the most important things in our society. And, that loneliness can be looked upon as an illness. (In some countries, this is an accepted fact.) I highly recommend Dianas book “Die neue Einsamkeit: Und wie wir sie als Gesellschaft überwinden können” or “The new lonley”. Diana and I talk about this “new lonely” and how it affects not only older people, but a whole new generation of people under 30. There is a certain way of living very casually, not committed to things and people, that leaves a lot of us sad and disconnected. Something that is sometimes hard to figure out or even realise. Especially since this generation is perfectly connected in the digital world. More than anyone else. This explains to me, why we get lots of requests at The New Health Club from young people in their 20 or 30 about micro dosing, and most people tell us they would like to feel, to reconnect, but often can’t say with what and how. The “new lonely”and the rise of psychedelics and psychedelic therapy, is strongly connected. And this is our big topic here.

Diana Kinnert - On TikTok, Mental Health and the Politics of Loneliness.

When I read about the “Veteran Navy SEAL Advocates for Psychedelic Assisted Therapy” called Marcus Capone, I was wondering, what was this all about? A Navy Seal and psychedelics? I kept reading and quickly Amber Capone, Marcus’ wife, was introduced in the articles, Amber wanted to save her husband from PTSD and, yes, suicide. And make it possible for war veterans to get in touch with psychedelic-assisted therapy by founding the organization Vet Solutions. Amber’s and Marcus’ mission today is to end the veteran suicide epidemic by providing resources, research, and advocacy for U.S. military veterans seeking psychedelic-assisted therapies. Vet Solutions helps veterans and their spouses to access treatment with psychedelic therapies including iboga/ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT, and ayahuasca. So far in the US. But their model can work on a global level. The story of Marcus and Amber is a pretty strong one. When Marcus was medically retired after 13 years and multiple combat deployments as a U.S. Navy SEAL, Marcus and Amber thought that life would return to normal. Instead, their struggle had just begun. Marcus was experiencing an escalating myriad of challenges, including depression, isolation, cognitive impairment, excessive alcohol use, headaches, insomnia, and impulsivity. Marcus was diagnosed with post-traumatic stress disorder (PTSD), but, instinctively, Amber felt there was more to be discovered. After learning about the effects of blast waves, concussive, and subconcussive brain injuries, everything started to become clear. Marcus’ military career as an explosives expert, combined with his prior years of contact sports, had left him with the invisible wounds of traumatic brain injury (TBI), a condition that has significant overlap with PTSD and is often not properly diagnosed. So here they are, on the podcast, talking about their journey. https://vetsolutions.org/

Amber & Marcus Capone - Helping Veterans to come back to life with Psychedelics

Meet the Plant Medicine Law Group , the first law firm to emerge in the space with the express purpose of serving the psychedelic and cannabis industries. Partners Adriana Kertzer, Serena Wu, and Hadas Alterman are entering their 8th month with a full roster corporate and nonprofit of clients in both industries. They are here today with the first attorney they added, Allison Hoots, who specializes in religious exemptions for psychedelic use, to reflect on their growth, what they’ve learned, and what they hope to accomplish moving forward. I am a really big fan of the Plant Medicine Law Group, since we started to be present in the psychedelic ecosystem at a similar time, and I love the way they look at psychedelics and the renaissance we are just experiencing. Also they contribute to one of the most important parts in the new psychedelic world: the legal framework.So how do you work in an industry that is working with mostly illegal substances? https://www.plantmedicinelaw.com/

The Plant Medicine Law Group - What it takes to be psychedelic lawyer.

Heard of the potential of psychedelics for new ideas on leadership and supporting your creativity as an entrepreneur or executive? Meet my guest and expert on this today! It is Jonathan de Potter, the founder of Behold Retreats a special legal, vetted and safe retreat for leaders, executives and entrepreneurs. And btw, a portion of Beholds revenues is going to Fireside Project - the free psychedelic harm reduction hotline. Jonathan talks to me about the psychedelic CEO, how integration of the psychedelic experience is on of the most important topics after the psychedelic experience itself, how new ideas for a company can come out of an experience all together. But also how much the, often stressed and high pressured personal life of a CEO is connected to all of this and that there is no end of evolution for your consciousness, even if you try so hard to achieve it. So if you you are an entrepreneur , CEO or in a leadership position and you know that the top down fear based hierarchy in companies is in the process of being replaced by a more servant leadership. And that we need new ideas, new structures and new insights for our world, not only in business. https://www.behold-retreats.com/ https://firesideproject.org/

Jonathan de Potter - What is a psychedelic CEO?

Yes, it’s the famous Hamilton Morris who is my guest today. Hamilton is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series “Hamilton's Pharmacopeia”, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Now Hamilton is on the third season of his show, which was released on January 4, 2021.The show runs on Vice TV and YT. Hamilton started to engage early into very personalised and you could say customised research of drugs and substances. He always had an interesting aura around him on camera, a mixture of a daring guinea pig and scientist. The episodes of his show had names, that made it clear . how un judgmental and curious Hamilton was approaching psychedelic substance as his topic. At this point in his life as a psychedelic expert, Hamilton is moving towards psychedelic research, inspired by the great american bio chemist Alexander Shulgin. (https://melmagazine.com/en-us/story/the-magic-chemicals-of-psychedelic-wizard-sasha-shulgin) So for the future, Morris has mainly the tweaking of molecules in mind, and that in the context of a university. Hamilton and I talk about why we are developing a new idea of drugs and psychedelics as we speak, the meaning of molecules and the freedom of researching new molecules, the advantages to approach psychedelics in a completely non-judgmental and undogmatic fashion, and of course we address Hamilton's favorite topic: the Sonoran Desert toad, or Bufo alvarius and the potent psychedelic compound called 5-MeO-DMT. https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia https://www.patreon.com/HamiltonMorris

Hamilton Morris - How to be non-judgemental with psychedelics.

The episode today will be in german, because my guest today has a good, informative way to talk about the new psychedelics, in german. Since we want to offer and communicate as much information as possible about the new psychedelics for everyone, once in a while we do a show in german. Dr. med. Andrea Jungaberle, based in Berlin, is a perfect guest for this. She is a co-founder and board member of the MIND Foundation. She also serves as OVID Health Systems’ Medical Director and MIND’s Director of Collaboration and Media. She is a clinical specialist in anaesthesia and emergency medicine and is currently training in cognitive behavioural psychotherapy. Andrea’s research interests revolve around the therapeutic application of altered states of consciousness, integration and the essential questions of death and dying. She has facilitated workshops on psychedelic integration with Dr. Henrik Jungaberle since 2015 and is a key contributor to the MIND Foundation’s BEYOND EXPERIENCE program. She is a certified Kundalini Yoga teacher, has participated in several accredited trainings in psychedelic therapy, and is part of the EPIsoDe study team, preparing to treat patients at Charité hospital in Germany’s first modern clinical trial involving psilocybin. Her interests in altered states of consciousness range from psychedelics to breathwork to yoga. In her latest audiobook “Yoga, Tee, LSD,” Andrea shines a light on the many ways humans modulate their consciousness, both intentionally and unintentionally. https://mind-foundation.org/ https://episode-study.de/hgf/

Dr. Andrea Jungaberle - On Mental Wellness, Mental Hellness & Mental Health.

Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health and I are talking about Field Trip’s mission to "bring the world to life through psychedelics and psychedelic-enhanced psychotherapy". Especially the opening of Ketamine Clinics, in the meantime in seven locations from Toronto to Amerstedam, has made Field Trip Health last year to one the most important forces in the field and last year the company even went public. Ronan, a lawyer by training, is also a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences Inc., a leading biotech company in the hemp and cannabis industries.It was fun to have Ronan on the show again and catch up, also because the world of psychedelics is changing every day. This time, next to Ketamine, we talk about if Ketamine Clinic should look like Soho House, if there is something like an agnostic molecule, we talk Demi Levato's video “Dancing with the devil'', where she shows herself overdosing and addressing her addiction. We talk about the exact meaning of “California Sober”, an approach to recovery that includes drinking alcohol and smoking cannabis in moderation and we discuss if biotech or the recreational side of psychedelics will win the race. So enjoy the show with Ronan and the birds singing in the background, while we are talking. https://www.fieldtriphealth.com/

Ronan Levy - Should a ketamine clinic make you feel good?

What if some people undergoing psychedelic assisted therapy rather have a picture of Manchester United or Britney Spears on the wall, instead of a buddha and yoga poses? Is this a question of class, just a different idea of spirituality and power objects? This is my favourite topic in the episode with Ben Sessa today. Dr. Ben Sessa is consultant psychiatrist, psychedelic therapist and chief medical officer at Awakn Life Sciences , UK’s first on-the-high-street provider of psychedelic-assisted psychotherapy. Awakn is researching, developing and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions, and is aiming to open 15 to 20 clinics across the UK and EU in the next 24 months. Patients will be able to self-refer or be referred by their GP (including NHS). Ben focuses on MDMA-assisted therapies, since the substance is further along in the research and legal processes then psilocybin.Though in the meantime, Ben and his team work also with Ketamine as a therapy tool. The need for psychedelic assisted therapy seems higher then ever. Ben tells me, 30 to 40 % of the British population is drinking in a harmful bracket now in the last 12 month of the pandemic. We talk about rather different ways of using psychedelics like ketamine for addiction, MDMA for obesity or psilocybin for anorexia, something Ben, as a fan of creative psychopharmacology, is interested in. We also address what happens, if depression and anti-depressants can become part your identity and how you might be able to get rid of your own old stories about yourself with the support of psychedelic assisted therapy. http://www.drsessa.com/ https://awaknlifesciences.com/

Dr. Ben Sessa - Why we need a curative psychiatry.

My guest today is Zac Kamenetz. Zac is a rabbi, community leader, and aspiring psychedelic chaplain based in Berkeley, CA. He holds an MA in Biblical literature and languages from UC Berkeley and the Graduate Theological Union and received rabbinic ordination in 2012. He is also the founder of the Shefa Foundation, for Psychedelic therapy grounded in Jewish spirituality. He was part of a psilocybin study that dosed clergy of various traditions with psilocybin, the psychoactive compound found in psilocybin mushrooms. This conversation is not only exploring new territory like judaism and psychedelics. Zac and I talk the future of psychedelic therapy, in Zac case that could be jewish psychedelic teraphy, with a “jewish set and setting” as Zac describes it. We talk epigenetic trauma and experinces, the new openeness towards religions and psychedelics and why there might be the new health clubs shuls one day. Zac and I talk about how non-jewish people, like me, should start talking to other non- jewish people about the Holocaust, and how psychedelic insight can contribute to this: the recognition and the embracing of pain, guilt and responsibility. I did not expect the conversation and the podcast with Zac would turn into a psychedelic integration session. For me. But the german and jewish history is something that has been on my mind since forever. And now it is time to bring it back as a result of a psychedelic experiences. https://www.shefaflow.org/ https://2021.jewishpsychedelicsummit.org/

Zac Kamenetz - We will have jewish psychedelic therapy.

Today, my guest is Lars Christian Wilde, the President, Chief Business Officer and Co‑founder of Compass Pathways. Compass is a “mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.” as they describe themselves. Compass was one of the first companies engaging in a bigger vision of the substance psilocybin. But back to Lars. He is a special guest to me, since I like his open mind. I remember talking to Lars in one of our first podcasts about vaccine against depression in the future. I also remember how openly Lars talked about his treatment-resistant depression and anxiety disorder and the effects it had on him and the people in his life. He told me about his treatment with psilocybin, that helped him tremendously to begin a new life with a different mental health set. I am always a fan of people, especially entrepreneurs in the psychedelic field, that share their psychedelic experiences and are personally affected by the power of psychedelic substances. In 2020 lot of things have happened at Compass Pathways. In September 2020 the company became a public company, listing their stock on Nasdaq and raising $146.6 million. Compass became one of the most exciting company in the field. Lars and I catch up, what is happening in the Compass World right now. How does a psychedelic public company feels and works different? How does the Compass and Sheppard Pratt collaboration look like, since Compass is opening a Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland, to do more research. Their psychiatry department exists since the 1800s. We talk about how Compass works with the Charité hospital in Berlin and how to do conduct a study in times of Covid at all, we discuss COMP360, a psilocybin therapy trial for treatment-resistant depression designed by Compass for future treatments of depression (https://compasspathways.com/)

Lars Christian Wilde - On markets, psilocybin & Compass Pathways.

I am happy to have Jeremy Weate, board member of Universal Ibogaine, as my guest on the show. He spent 15 years working as a consultant on natural resource governance, providing advice to governments, companies and civil society organisations in over 20 countries. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti. In 2018, Jeremy helped set up Tabula Rasa Retreat in Portugal, now one of the leading ibogaine treatment facilities in the world. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK. Jeremy and I talk about the face and rules of modern addiction, the coming importance of Ibogaine and why you can’t keep a good molecule down, which is a british, understated way to say: Ibogaine will become a mayor player in the new word of psychedelics treatments. He is now a board member of "Universal Ibogaine" (https://www.ibogaineinc.com/) a Vancouver based company which aims to build a global network of holistic ibogaine-assisted addiction treatment clinics, operating under the brand Clear Sky Recovery, utilizing a proprietary Ibogaine assisted psychotherapy treatment protocol. The treatment protocol has successfully disrupted opioid addiction for over 3,500 people and delivers up to 95% successful detox.

Dr. Jeremy Weate - Is Ibogaine the “grandaddy” of psychedelics ?

I talk to, Charley Wininger. Great guy, experienced psychedelic pro. He is a licensed Psychoanalyst and Mental Health Counselor for individuals and couples. Charley is an author and an expert on Psychedelic Drugs, the 71-year-old is a also a relationship counsellor who calls MDMA the “relationship super glue” and just published the book called. “Listening to ecstasy” When reading about Charleys book, I was wondering: is our connection on a neural level the most important one? Charley must know. In is book he talks about his “MDMA” journey with his wife Shelley, since the two of them, you could say, became relationship scientist with the support of ecstasy. Since the ideas of marriage and relationships have changed big time and we seem to need new tools to understand each others minds and hearts. Charley and I talk about the rediscovery of MDMA in the context of the psychedelic renaissance. And how MDMA could supports couples therapy in the future and what that would mean for love. Enjoy Charley explaining a new possible “relationship glue” called MDMA. https://www.charleywininger.com/

Charley Wininger - Will we have couples therapy on MDMA?

Psychedelics are experiencing a renaissance, developing into a tool to help us go through life. But what are LSD, magic mushrooms, psilocybin and MDMA or Ketamine exactly doing for our mental health, personal progress and optimisation? Will they change our lifestyles and lives forever? I am sure, they will. On the “New Healthclub Podcast” I talk to real innovators, leaders and disrupters from the emerging world of psychedelics.

hubhopper

THE NEW HEALTH CLUB

hubhopper